D GEN LTD has a total of 38 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROMIS NEUROSCIENCES INC, AMORFIX LIFE SCIENCES LTD and DMNOMORE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | New Zealand | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | South Africa | 2 | |
#9 | Argentina | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Collinge John | 35 |
#2 | Jackson Graham Stuart | 10 |
#3 | Clarke Anthony Russell | 7 |
#4 | Wadsworth Jonathan David Frank | 6 |
#5 | Clarke Anthony R | 5 |
#6 | Jackson Graham S | 5 |
#7 | Nicoll Andrew J | 5 |
#8 | Weissmann Charles | 4 |
#9 | Enari Masato | 4 |
#10 | Flechsig Eckhard | 4 |
Publication | Filing date | Title |
---|---|---|
NZ335290A | Diagnosis an typing of spongiform encephalopathy (or bovine spongiform encephalopathy (BSE)) |